Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Akero Therapeutics Inc fell by 15.67m. Cash Flow from Financing totalled 353.32m or -- of revenues. In addition the company used 145.37m for operations while cash used for investing totalled 223.62m.
Cash flow per share | -3.41 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 11.53 |
---|---|
Tangible book value per share | 11.53 |
More ▼
Balance sheet in USDView more
Current ratio | 24.89 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0438 |
---|---|
Total debt/total capital | 0.042 |
More ▼